A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
about
A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A phase I/Ib study of trametin ...... ts with advanced solid tumors.
@en
A phase I/Ib study of trametinib
@nl
type
label
A phase I/Ib study of trametin ...... ts with advanced solid tumors.
@en
A phase I/Ib study of trametinib
@nl
prefLabel
A phase I/Ib study of trametin ...... ts with advanced solid tumors.
@en
A phase I/Ib study of trametinib
@nl
P2093
P2860
P1476
A phase I/Ib study of trametin ...... ts with advanced solid tumors.
@en
P2093
Akihira Mukaiyama
Atsuko Takasu
Daisuke Naruge
Fumio Nagashima
Hideki Matsushita
Hiroshi Kitamura
Junji Furuse
Kazuhiko Nakagawa
Shinichi Nishina
Takayasu Kurata
P2860
P2888
P304
P356
10.1007/S10637-015-0270-2
P577
2015-08-12T00:00:00Z